Board
Screen
Heat
Cal
Watch
News
Blog
TV
Home
/
PCVX
Home
/
PCVX

NASDAQ
$64.515
$64.515

Overview

Price performance
Low
$60.04
High
$65.00
Market open. Last updated: Nov 4, 2026, 8:07 PM UTC
$
64.52
3.71 (6.09%)
Average, 50 days
$61.54
$57.17
Open
$62.87
Previous close
$60.81
52-week high
$90.75
Oct 5, 2026 (2 months ago)
52-week low
$39.87
Nov 5, 2025 (13 months ago)
61.81%

Valuation & Estimates

Earnings

Financials

Insider Trading

Peer Analysis

Insights & Activity

Market Cap
10.15B
Volume
1 208 682
Total Return (3M)
18.86%
Total Return (1Y)
57.20%
12.45
Sector
Healthcare
Links
Tags
Healthcare
Biotechnology
NASDAQ
US
Website
vaxcyte.com
About
Vaxcyte, Inc. is a biotechnology firm in the clinical development stage, dedicated to creating innovative protein-based vaccines. Its primary objective is to either prevent or manage bacterial infectious diseases. The company's leading vaccine candidate is VAX-24, an experimental 24-valent pneumococcal conjugate vaccine currently undergoing Phase 1/2 clinical trials, intended to address invasive pneumococcal disease and pneumonia. Beyond its flagship candidate, Vaxcyte is also advancing several other vaccine programs: VAX-XP, designed to offer protection against emergent bacterial strains and counter antimicrobial resistance; VAX-A1, a conjugate vaccine formulation aimed at Group A Streptococcus; and VAX-PG, a novel protein vaccine specifically developed to target the key pathogen responsible for periodontitis. The organization, which was initially established as SutroVax, Inc., officially rebranded as Vaxcyte, Inc. in May 2020. Founded in 2013, its corporate headquarters are situated in San Carlos, California.

Frequently asked questions

PCVX · Vaxcyte, Inc.

01What is Vaxcyte, Inc. stock price today?

The current price of PCVX is $64.52 — it has increased by 6.09% since the previous close. Data as of Nov 4, 2026.

02Is Vaxcyte, Inc. stock price growing?

PCVX is up 3.86% over the past week, up 15.09% over the past month and up 57.20% over the past year. The price is above its 200-day moving average of $57.17.

03What is PCVX stock forecast?

Analysts' average 12-month price target for PCVX is $122.33, which implies 89.61% upside from the current price. Individual estimates range from $120.00 to $125.00.

04What do analysts say about PCVX stock?

Of the 11 analysts covering Vaxcyte, Inc., 1 rates it a strong buy, 9 rate it a buy and 1 rates it a hold. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.

05What is Vaxcyte, Inc. market cap?

Vaxcyte, Inc. has a market capitalization of $10.15B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.

06What were Vaxcyte, Inc. earnings last quarter?

In its most recent quarterly report, Vaxcyte, Inc. posted a loss of $1.97 per share against an estimate of -$2.06, beating expectations by 4.37%. Upcoming reports are listed in the earnings calendar.

07Does Vaxcyte, Inc. pay dividends?

Vaxcyte, Inc. has not paid any dividends over the past year.

08How volatile is PCVX stock?

In the latest trading session PCVX moved between $60.04 and $65.00, a range of 7.69% of its current price.

09Should I invest in Vaxcyte, Inc. stock?

Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Vaxcyte, Inc. shows a strong buy rating today and a strong buy rating on the weekly timeframe. Technical ratings are indicators, not investment advice.

10What are PCVX stock 52-week high and low?

Over the past 52 weeks PCVX has traded between $39.87 and $90.75. The current price is 28.91% below its 52-week high.

Figures as of Nov 4, 2026. This information is provided for general purposes only and is not investment advice.